Source: Annual Congress 2010 - Clinical Trials: "EURO VENT - endobronchial valves in heterogeneous emphysema patients", "EASE - randomized trial of airway bypass in homogeneous emphysema"
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Sybrecht (Homburg/Saar, Germany). The EASE trial: rationale, study design and early results. Annual Congress 2010 - Clinical Trials: "EURO VENT - endobronchial valves in heterogeneous emphysema patients", "EASE - randomized trial of airway bypass in homogeneous emphysema"

Member's Comments

No comment yet.

Related content which might interest you: The AMBITION study: design and results Source: International Congress 2014 – Combination therapy in pulmonary arterial hypertension (PAH): the evidence grows Year: 2014 The ESCAPE study: design and exposure assessment results Source: Annual Congress 2013 –Highlights from ESCAPE Year: 2013 Pneumostomy: an operative proposal - pilot study Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery Year: 2018 COPD and Seretide: a multi-centre intervention and characterisation (COSMIC) study: rationale and baseline characteristics Source: Eur Respir J 2002; 20: Suppl. 38, 241s Year: 2002 From research question to dissemination: how to design, analyse and present study results Source: Breathe, 14 (3) 232; 10.1183/20734735.020018 Year: 2018 RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021 Can locus of control become a useful indicator for a multicentre study: data from the Edu-Care® study Source: Eur Respir J 2002; 20: Suppl. 38, 263s Year: 2002 Smartphone-enabled detection of COugh in COvid-19 (COCO) – preliminary analysis of an exploratory, observational cohort study Source: Virtual Congress 2021 – E-health for COVID-19 Year: 2021 Late Breaking Abstract - IPF symptoms’ course during a 3-month observation: FIBRONET observational study’s preliminary results. Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017 The study design Source: ERS Course 2015 Year: 2015 A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness? Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018 Year: 2018 Validation of the codex index in patients with COPD enrolled in randomized clinical trials: A post-hoc analysis of the trilogy, trinity and tribute studies. Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study Source: ERJ Open Res, 4 (4) 00084-2018; 10.1183/23120541.00084-2018 Year: 2018 Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment Year: 2021